Abela GS. Cholesterol crystals piercing the arterial plaque and intima trigger local and systemic inflammation. J Clin Lipidol. 2010a;4(3):156–64.

Article  PubMed  Google Scholar 

Abela GS. Role of cholesterol crystals in myocardial infarction and stroke. Clinical Lipidology. 2010b;5(1):57–69.

Article  CAS  Google Scholar 

Abela GS, Aziz K, Vedre A, Pathak DR, Talbott JD, DeJong J. Effect of cholesterol crystals on plaques and intima in arteries of patients with acute coronary and cerebrovascular syndromes. Am J Cardiol. 2009;103(7):959–68.

Article  CAS  PubMed  Google Scholar 

Alves JC, Sonego F, Souto FO, Freitas A, Verri WA, Auxiliadora-Martins M, Basile A, McKenzie AN, Xu DM, Cunha FQ, Liew FY. Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nat Med. 2010;16(6):708-U113.

Article  Google Scholar 

Araki N, Johnson MT, Swanson JA. A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages. J Cell Biol. 1996;135(5):1249–60.

Article  CAS  PubMed  Google Scholar 

Aslanian AM, Charo IF. Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis. Circulation. 2006;114(6):583–90.

Article  CAS  PubMed  Google Scholar 

Cayrol C, Girard JP. Interleukin-33 (IL-33): a critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokine. Cytokine. 2022;156: 155891.

Article  CAS  PubMed  Google Scholar 

Chen Y, Popko B. Cholesterol crystals impede nerve repair. Science. 2018;359(6376):635–6.

Article  CAS  PubMed  Google Scholar 

Demirel I, Persson A, Brauner A, Särndahl E, Kruse R, Persson K. Activation of NLRP3 by uropathogenic Escherichia coli is associated with IL-1β release and regulation of antimicrobial properties in human neutrophils. Sci Rep. 2020;10(1):21837.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dhillon OS, Narayan HK, Khan SQ, Kelly D, Quinn PA, Squire IB, Davies JE, Ng LL. Pre-discharge risk stratification in unselected STEMI: is there a role for ST2 or its natural ligand IL-33 when compared with contemporary risk markers? Int J Cardiol. 2013;167(5):2182–8.

Article  PubMed  Google Scholar 

Donat C, Thanei S, Trendelenburg M, et al. Binding of von Willebrand factor to complement C1q decreases the phagocytosis of cholesterol crystals and subsequent IL-1 secretion in macrophages. Front Immunol. 2019. https://doi.org/10.3389/fimmu.2019.02712.

Article  PubMed  PubMed Central  Google Scholar 

Doring Y, Drechsler M, Wantha S, Kemmerich K, Lievens D, Vijayan S, Gallo RL, Weber C, Soehnlein O. Lack of neutrophil-derived CRAMP reduces atherosclerosis in mice. Circ Res. 2012;110(8):1052-U1073.

Article  PubMed  Google Scholar 

Drechsler M, Megens RT, van Zandvoort M, Weber C, Soehnlein O. Hyperlipidemia-Triggered Neutrophilia Promotes Early Atherosclerosis. Circulation. 2010;122(18):1837–45.

Article  CAS  PubMed  Google Scholar 

Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nuñez G, Schnurr M, Espevik T, Lien E, Fitzgerald KA, Rock KL, Moore KJ, Wright SD, Hornung V, Latz E. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2010;464(7293):1357–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Falkenberg M, Tom C, DeYoung MB, Wen S, Linnemann R, Dichek DA. Increased expression of urokinase during atherosclerotic lesion development causes arterial constriction and lumen loss, and accelerates lesion growth. Proc Natl Acad Sci U S A. 2002;99(16):10665–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ferri N, Tibolla G, Pirillo A, Cipollone F, Mezzetti A, Pacia S, Corsini A, Catapano AL. Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels. Atherosclerosis. 2012;220(2):381–6.

Article  CAS  PubMed  Google Scholar 

Fuchs TA, Abed U, Goosmann C, Hurwitz R, Schulze I, Wahn V, Weinrauch Y, Brinkmann V, Zychlinsky A. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol. 2007;176(2):231–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grootaert MO, Schrijvers DM, Hermans M, Van Hoof VO, De Meyer GR, Martinet W. Caspase-3 Deletion Promotes Necrosis in Atherosclerotic Plaques of ApoE Knockout Mice. Oxid Med Cell Longev. 2016;2016:3087469.

Article  PubMed  PubMed Central  Google Scholar 

Haigh S, Li X, Bordan Z, Sellers H, Meadows ML, Barman S, Fulton D. GAL3 excretion regulates smooth muscle cell survival and proliferation. FASEB J. 2022. https://doi.org/10.1096/fasebj.2022.36.S1.L7886.

Article  Google Scholar 

Hakkim A, Fuchs TA, Martinez NE, Hess S, Prinz H, Zychlinsky A, Waldmann H. Activation of the Raf-MEK-ERK pathway is required for neutrophil extracellular trap formation. Nat Chem Biol. 2011;7(2):75–7.

Article  CAS  PubMed  Google Scholar 

Heller EA, Liu E, Tager AM, Yuan Q, Lin AY, Ahluwalia N, Jones K, Koehn SL, Lok VM, Aikawa E, Moore KJ, Luster AD, Gerszten RE. Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells. Circulation. 2006;113(19):2301–12.

Article  CAS  PubMed  Google Scholar 

Ho-Tin-Noé B, Vo S, Bayles R, Ferrière S, Ladjal H, Toumi S, Deschildre C, Ollivier V, Michel J-B. Cholesterol crystallization in human atherosclerosis is triggered in smooth muscle cells during the transition from fatty streak to fibroatheroma. J Pathol. 2017;241(5):671–82.

Article  PubMed  Google Scholar 

Ionita MG, van den Borne P, Catanzariti LM, Moll FL, de Vries JPPM, Pasterkamp G, Vink A, de Kleijn DPV. High neutrophil numbers in human carotid atherosclerotic plaques are associated with characteristics of rupture-prone lesions. Arterioscler Thromb Vasc Biol. 2010;30(9):1842-U1374.

Article  CAS  PubMed  Google Scholar 

Kiyak JH. Cholesterol crystals, smooth muscle cells and new data on the genesis of atherosclerosis. Pol J Pathol. 1997;48(1):49–55.

CAS  PubMed  Google Scholar 

Li X, Bayliss G, Zhuang S. Cholesterol Crystal embolism and chronic kidney disease. Int J Mol Sci. 2017;18(6):1120.

Article  PubMed  PubMed Central  Google Scholar 

Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868–74.

Article  CAS  PubMed  Google Scholar 

Liew FY, Girard J-P, Turnquist HR. Interleukin-33 in health and disease. Nat Rev Immunol. 2016;16(11):676–89.

Article  CAS  PubMed  Google Scholar 

Lim RS, Suhalim JL, Miyazaki-Anzai S, Miyazaki M, Levi M, Potma EO, Tromberg BJ. Identification of cholesterol crystals in plaques of atherosclerotic mice using hyperspectral CARS imaging. J Lipid Res. 2011;52(12):2177–86.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lopez-Castejon G, Brough D. Understanding the mechanism of IL-1 beta secretion. Cytokine Growth Factor Rev. 2011;22(4):189–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mach F, Schönbeck U, Sukhova GK, Atkinson E, Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature. 1998;394(6689):200–3.

Article  CAS  PubMed  Google Scholar 

Mani AM, Chattopadhyay R, Singh NK, Rao GN. Cholesterol crystals increase vascular permeability by inactivating SHP2 and disrupting adherens junctions. Free Radic Biol Med. 2018;123:72–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McLaren JE, Michael DR, Salter RC, Ashlin TG, Calder CJ, Miller AM, Liew FY, Ramji DP. IL-33 reduces macrophage foam cell formation. J Immunol. 2010;185(2):1222–9.

Article  CAS  PubMed  Google Scholar 

Megens RTA, Vijayan S, Lievens D, Döring Y, van Zandvoort MAMJ, Grommes J, Weber C, Soehnlein O. Presence of luminal neutrophil extracellular traps in atherosclerosis. Thromb Haemost. 2012;107(03):597–8.

Article  CAS  PubMed  Google Scholar 

Nidorf SM, Fiolet A, Abela GS. Viewing atherosclerosis through a crystal lens: How the evolving structure of cholesterol crystals in atherosclerotic plaque alters its stability. J Clin Lipidol. 2020;14(5):619–30.

Article  PubMed  Google Scholar 

Niyonzima N, Bakke SS, Gregersen I, Holm S, Sandanger O, Orrem HL, Sporsheim B, Ryan L, Kong XY, Dahl TB, Skjelland M, Sorensen KK, Rokstad AM, Yndestad A, Latz E, Gullestad L, Andersen GO, Damas JK, Aukrust P, Mollnes TE, Halvorsen B, Espevik T. Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis. EBioMedicine. 2020;60:102985.

Article  PubMed  PubMed Central  Google Scholar 

Paramel GV, Karadimou G, Eremo AG, Ljungberg LU, Hedin U, Olofsson PS, Folkersen L, Paulsson-Berne G, Sirsjö A, Fransén K. Expression of CARD8 in human atherosclerosis and its regulation of inflammatory proteins in human endothelial cells. Sci Rep. 2020;10(1):19108.

Article